• Yan Fu, Peizhun Du, Jing Zhao, Cheng'en Hu, Yunyun Qin, and Guangjian Huang.
• Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China.
• Yonsei Med. J. 2018 Dec 1; 59 (10): 1150-1158.

AbstractGastric cancer (GC) is the third leading cause of cancer-related deaths worldwide. GC stem-like cells (GCSCs), with unlimited self-renewal, differentiation, and tumor-regenerating capacities, contribute significantly to the refractory features of GC and have gained increasing attention for their role in GC drug resistance, relapse, and metastasis. Therapies targeting GCSCs seem to be one of the most promising methods to improve the outcomes of GC patients. Extensive investigations have attempted to outline the regulatory mechanisms in GCSCs and to develop GCSCs-targeting therapies with which to diminish GC drug resistance, metastasis and relapse. To the best of our knowledge, there is a lack of reviews summarizing these studies. In this review, we systematically recapitulated findings regarding the regulatory mechanisms of GCSCs, as well as therapies that target GCSCs, hoping to support the development of prognostic biomarkers and GCSCs-targeting anticancer therapies in GC.© Copyright: Yonsei University College of Medicine 2018.

17 keywords...

hide…